ID: ALA162191

Max Phase: Preclinical

Molecular Formula: C13H15N3O2

Molecular Weight: 245.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1c(O)nc(O)nc1Nc1ccc(C)cc1

Standard InChI:  InChI=1S/C13H15N3O2/c1-3-10-11(15-13(18)16-12(10)17)14-9-6-4-8(2)5-7-9/h4-7H,3H2,1-2H3,(H3,14,15,16,17,18)

Standard InChI Key:  ONWSNULKQCTLMM-UHFFFAOYSA-N

Associated Targets(non-human)

DNA topoisomerase III 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 245.28Molecular Weight (Monoisotopic): 245.1164AlogP: 2.50#Rotatable Bonds: 3
Polar Surface Area: 78.27Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.61CX Basic pKa: 0.54CX LogP: 4.22CX LogD: 4.22
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.77Np Likeness Score: -1.00

References

1. Trantolo DJ, Wright GE, Brown NC..  (1986)  Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines.,  29  (5): [PMID:3084785] [10.1021/jm00155a016]

Source